Publication date: November 2026 Source: American Journal of Transplantation, Volume 26, Issue 11 Author(s): Katsutaka Mineura, Charles R. Liu, Junedh M. Amrute, Shinichi Kawana, Fatima H. Elmenshawy, Jonathan L. Perez, Will Lounsbery-Scaife, Nikita Poddar, Venkatrao Nunna, Wenjun Li, Yuriko Terada, Austin Meadows, Gyu Seong Heo, William Wang, Maria Giulia Davighi, Judit Morla-Folch, Seokchan Park, Gabriel Laghlali, Eleanor Burgess, Michael Schotsaert
Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation. // American Journal of Transplantation. – URL: https://www.sciencedirect.com/science/article/pii/S1600613526025827?dgcid=rss_sd_all
Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation. American Journal of Transplantation. https://www.sciencedirect.com/science/article/pii/S1600613526025827?dgcid=rss_sd_all
“Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation.” American Journal of Transplantation.
@article{article34916,
title = {Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation},
journal = {American Journal of Transplantation},
url = {https://www.sciencedirect.com/science/article/pii/S1600613526025827?dgcid=rss_sd_all}
}